Scientists have revealed that statins drugs can slash the risk of dementia by a quarter.
Researchers from the National Taipei Medical University and the National Yang-Ming University found that the higher the dose of the drugs and the longer patients took them, the greater was the potential for warding off the disease, the Daily Express reported.
According to the study, patients prescribed the drugs at any time were 22 per cent less likely to suffer brain problems than those who never took them, while women saw the greatest benefit, with the risk reduced by 24 per cent.
Dr Simon Ridley, head of research at Alzheimer's Research UK, said that similar studies in other countries have also associated statin use with lower dementia risk.
The study is published in the International Journal of Cardiology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
